FDA
approval
· 2026-01-05
FDA Approved: SUCRALFATE ORAL SUSPENSION — Original Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved Glenmark's generic sucralfate oral suspension via Original Application (ANDA) to provide the same indications as the reference product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SUCRALFATE ORAL SUSPENSION (SUCRALFATE)